Home > News > Nanoforum commercialisation workshop identifies need for greater industrial engagement
June 28th, 2007
Nanoforum commercialisation workshop identifies need for greater industrial engagement
Abstract:
Nanoforum, the thematic network funded by the EU under the Fifth Framework Programme (FP5), has identified three key challenges for the development of nanotechnology in Europe: a low level of venture capital investment, low patenting rates, and low investment from industry
According to the Nanoforum report, the first priority is to increase the very low proportion (only 3.5%) of global nanotechnology venture capital invested in Europe.
Despite public funding being on a par with that of the US, Europe, it seems, is also lagging behind in the number of nanotechnology patents granted. Industrial investment in nanotechnology is also only half that in the US and Japan.
For the authors of the report, the low level of venture capital is largely due to a shortage of suitable investment targets. Companies lack focused business models, commercial experience, and exit strategies. Whilst public funding sources may take the place of venture capital, the concern is that companies will then miss out on the other benefits that investors would bring, such as in-depth industry awareness and networks.
Source:
cordis.europa.eu
Bookmark:
| Related News Press |
Announcements
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Finding quantum order in chaos May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||